Rockleo , very good points ,
One thing I look little different at , study for long haulers ..
Yes , those patients might have many , many serious problems ,but we know that they will not take for a study people with irreversible lungs or kidney damage , etc...
But we know that many people have reversible problems ,
including , that so far we don't see patients on leronlimab , developing coagulopathies ...
I believe that Leronlimab will help many of those long haulers , and with right protocol it will show the results in the study..
But as always IMO only...